HLA
短名 | HLA |
Journal Impact | 5.86 |
国际分区 | PATHOLOGY(Q1) |
期刊索引 | SCI Q1中科院 4 区 |
ISSN | 2059-2302, 2059-2310 |
h-index | 107 |
国内分区 | 医学(4区)医学细胞生物学(4区)医学免疫学(4区)医学病理学(4区) |
HLA 发表完整的原创文章、简短的交流、评论和评论,涵盖免疫遗传控制的各个方面。范围包括对免疫系统分子的功能、生化和遗传学研究,包括细胞表面受体及其配体,包括细胞因子、趋化因子、粘附和共刺激分子、抗原受体,如 TCR、NKR、CD1、PAMP 、IGS、KIR 以及主要组织相容性复合体的基因和产物,包括经典和非经典 HLA 分子。论文应描述体外或动物模型的原始研究,或者是反映实体器官或造血干细胞移植免疫遗传学、自身免疫、传染性免疫、过敏、肿瘤免疫、疫苗科学、妊娠和疾病易感性的临床研究。
期刊主页投稿网址涉及主题 | 生物遗传学医学免疫学化学生物化学抗原基因人类白细胞抗原等位基因计算生物学计算机科学生态学内科学 |
出版信息 | 出版商: Wiley-Blackwell Publishing Ltd,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2016,原创研究文献占比: 89.83%,自引率:40.70%, Gold OA占比: 32.47% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Characterisation of the novel <i>HLA‐DPB1*1618:01</i> allele by sequencing‐based typing
2024-9-1
The novel <scp>HLA</scp> class I allele <i>HLA‐C*07:02:81</i> differs from <i>HLA‐C*07:02:01:01</i> by a synonymous mutation
2024-9-1
Characterisation of two novel <scp>HLA</scp>‐B alleles, <i>B*13:194</i> and <i>B*15:694</i> in individuals from Lithuania
2024-9-1
Characterisation of the novel <i>HLA‐B*51:411</i> allele by sequencing‐based typing
2024-9-1
Characterisation of the novel <i>HLA‐A*26:247</i> allele by sequencing‐based typing
2024-9-1
Seven new <scp>HLA</scp> alleles characterised by next‐generation sequencing
2024-9-1
Characterisation of the novel <i>HLA‐DQA1*01:02:24</i> allele by sequencing‐based typing
2024-9-1
Identification of the novel <i>HLA‐DQA1*03:79</i> allele in a candidate bone marrow donor by next generation sequencing
2024-9-1
Characterisation of the novel <i>HLA‐B*18:37:03</i> allele, first identified in a Brazilian individual
2024-9-1
Characterisation of the novel <i>HLA‐DQB1*05:305</i> allele using next‐generation sequencing
2024-9-1
Effect of angiotensin <scp>II</scp> type 1 receptor antibodies on graft function and survival in paediatric kidney transplant recipients
2024-9-1
Characterisation of the novel <i>KIR2DL1*00308</i> allele identified in a Chinese Han individual
2024-9-1
Identification of the novel <i>HLA‐DPB1*21:01:02</i> allele using nanopore sequencing technology
2024-9-1
Characterisation of the novel <i>HLA‐DRB3*02:202</i> allele by sequencing‐based typing
2024-9-1
The novel <i>HLA‐A*23:140</i> allele was identified in a <scp>Brazilian</scp> bone marrow volunteer donor
2024-9-1
Identification of nine novel <scp>HLA</scp> alleles by next‐generation sequencing in individuals from India
2024-9-1
Characterisation of the novel <i>HLA‐DPA1*01:12:03</i> allele by sequencing‐based typing
2024-9-1
Identification of the novel <i>HLA‐B*49:01:01:22</i> allele in an <scp>Indian</scp> renal transplant donor by next generation sequencing
2024-9-1
Refining <scp>cPRA</scp> calculation to improve <scp>HLA</scp> compatibility assessment in organ transplantation: A detailed picture of the <scp>Paris</scp> waiting list
2024-9-1
Issue Information
2024-8-28
Identification of four novel <scp>KIR</scp> alleles in haematopoietic stem cell donors of Indian origin
2024-8-1
Characterisation of a novel <i>HLA‐A*33:33:02</i> allele in two members of a North Indian family
2024-8-1
The novel <i>HLA‐A*02:1135</i> allele identified in a Chinese individual from New York City
2024-8-1
Killer‐cell immunoglobulin‐like receptor polymorphism is associated with <scp>COVID</scp>‐19 outcome: Results of a pilot observational study
2024-8-1
The full‐length genomic sequence of the <i>HLA‐G*01:19</i> allele
2024-8-1
Identification of the novel <i>HLA‐DRB3*03:69</i> allele by next‐generation sequencing
2024-8-1
The novel <i>HLA‐A*02:1146</i> allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual
2024-8-1
Identification of the novel <i>HLA‐C*07:1132</i> allele by next‐generation sequencing
2024-8-1
Calcium‐dependent <scp>HLA</scp>‐<scp>DQ</scp> epitope revealed by <scp>EDTA</scp> mediated inhibition of antibody reactions in the Luminex single antigen bead assay
2024-8-1
Identification of novel <i>HLA‐C*17:78</i> allele in North Indian individuals
2024-8-1
The novel <i>HLA‐C*15:279</i> allele, identified by <scp>Sanger</scp> dideoxy nucleotide sequencing in a Chinese individual
2024-8-1
Eight new variants of <i>HLA‐DQB1*03</i> identified by next‐generation sequencing
2024-8-1
A simple predictor for donor‐specific anti‐<scp>HLA</scp> antibody desensitisation in haploidentical haematopoietic stem cell transplantation
2024-8-1
The novel <i>HLA‐DPB1*04:02:01:44</i> allele identified in a volunteer bone marrow donor
2024-8-1
Identification of the novel allele <i>HLA‐DQB1*06:02:61</i> by next‐generation sequencing
2024-8-1
Characterisation of the novel <i>HLA‐C*07:02:151</i> allele by sequencing‐based typing
2024-8-1
Extending <scp>HLA</scp> allele sequences using next‐generation sequencing technology
2024-8-1
Characterisation of the novel <i>HLA‐DQB1*06:02:62</i> allele using short‐ and long‐read sequencing technologies
2024-8-1
Identification of the novel <i>HLA‐B*51:360</i> allele in a Chinese individual
2024-8-1
The novel <i>HLA‐A*24:618</i> allele identified in Ecuadorian individual from New York City
2024-8-1
Identification of the novel <i>HLA‐A*02:01:189</i> allele
2024-8-1
The novel <i>HLA‐A*24:617</i> allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual
2024-8-1
Characterisation of the novel <i>HLA‐A*24:630</i> allele by sequencing‐based typing
2024-8-1
A novel <i>HLA‐C*18</i> variant allele, <i>HLA‐C*18:20</i>, identified by next‐generation sequencing
2024-8-1
High resolution <scp>HLA</scp> genotyping with third generation sequencing technology—A multicentre study
2024-8-1
<i>MICB*002:06</i>, a novel exonic variant of <scp>MICB</scp> (<scp>MHC</scp> class I chain‐related gene B)
2024-8-1
Identification of the novel allele, <i>HLA‐DQB1*03:517</i>, in a <scp>Saudi</scp> individual
2024-8-1
Identification of the novel <i>HLA‐DPB1*14:01:15</i> allele in a Brazilian bone marrow donor
2024-8-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远